![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | G01N 33/53 | |
A61K 39/395 |
(11) | Number of the document | 2652498 |
(13) | Kind of document | T |
(96) | European patent application number | 11848523.4 |
Date of filing the European patent application | 2011-12-16 | |
(97) | Date of publication of the European application | 2013-10-23 |
(45) | Date of publication and mention of the grant of the patent | 2018-04-18 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2011/065410 |
Date | 2011-12-16 |
(87) | Number | WO 2012/083132 |
Date | 2012-06-21 |
(30) | Number | Date | Country code |
459760 P | 2010-12-16 | US | |
201161465425 P | 2011-03-18 | US | |
201161484650 P | 2011-05-10 | US | |
201161574485 P | 2011-08-02 | US | |
201161557295 P | 2011-11-08 | US |
(72) |
ARRON, Joseph R., US
ERICKSON, Richard W., US
FREEMER, Michelle, US
HAZEN, Meredith, US
JIA, Guiquan, US
MATTHEWS, John G., US
PUTNAM, Wendy, US
SCHEERENS, Heleen, US
ZHENG, Yanan, US
|
(73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
(54) | DIAGNOSIS AND TREATMENTS RELATING TO TH2 INHIBITION |
DIAGNOSIS AND TREATMENTS RELATING TO TH2 INHIBITION |